Hydrocephalus, cerebral vasospasm, and delayed cerebral ischemia following non-aneurysmatic spontaneous subarachnoid hemorrhages: an underestimated problem.


Journal

Neurosurgical review
ISSN: 1437-2320
Titre abrégé: Neurosurg Rev
Pays: Germany
ID NLM: 7908181

Informations de publication

Date de publication:
22 Dec 2022
Historique:
received: 30 08 2022
accepted: 27 11 2022
revised: 13 11 2022
entrez: 22 12 2022
pubmed: 23 12 2022
medline: 27 12 2022
Statut: epublish

Résumé

Non-aneurysmal subarachnoid hemorrhage (NASAH) is rare and mostly benign. However, complications such as cerebral vasospasm (CV), delayed cerebral ischemia (DCI), or post-hemorrhagic hydrocephalus (HC) may worsen the prognosis. The aim of this study was to evaluate the rate of these complications comparing perimesencephalic (PM) and non-perimesencephalic (NPM) SAH. Monocentric, retrospective analysis of patients diagnosed with NASAH from 01/2010 to 01/2021. Diagnosis was set only if vascular pathologies were excluded in at least one digital subtraction angiography, and NASAH was confirmed by cranial computed tomography (cCT) or lumbar puncture (LP). One hundred patients (62 female) with a mean age of 54.9 years (27-84) were identified. Seventy-three percent had a World Federation of Neurological Surgeons (WFNS) grading scale score I, while 9% were WFNS score IV or V at the time of admission. SAH was diagnosed by cCT in 86%, in 14% by lumbar puncture. Twenty-five percent necessitated short-term CSF diversion by extraventricular drainage or lumbar drainage, whereof 7 suffered from long-term HC treated with ventriculoperitoneal shunting (VPS). One patient without a short-term CSF drainage developed long-term HC. Ten percent developed CV, four of whom received intraarterial spasmolysis. Radiological DCI was diagnosed in 2%; none of these correlated with CV. Despite a mortality of 3% occurring solely in NPM SAH, the analyzed complication rate was comparable in both groups. We observed post-hemorrhagic complications in 35% of cases during the first 3 weeks after bleeding, predominantly in patients with NPM SAH. For this reason, close observation and cranial imaging within this time may be indicated not to overlook these complications.

Identifiants

pubmed: 36547720
doi: 10.1007/s10143-022-01919-9
pii: 10.1007/s10143-022-01919-9
pmc: PMC9780132
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

23

Informations de copyright

© 2022. The Author(s).

Références

Neurology. 1992 Sep;42(9):1805-7
pubmed: 1513471
Brain. 2001 Feb;124(Pt 2):249-78
pubmed: 11157554
Stroke. 2009 Jun;40(6):1963-8
pubmed: 19359629
J Stroke Cerebrovasc Dis. 2005 Nov-Dec;14(6):267-71
pubmed: 16518463
Neurology. 1985 Apr;35(4):493-7
pubmed: 3982634
Lancet. 1991 Oct 19;338(8773):964-8
pubmed: 1681340
Neurocrit Care. 2016 Feb;24(1):104-9
pubmed: 26136147
J Clin Neurosci. 2009 Jul;16(7):904-8
pubmed: 19362482
AJNR Am J Neuroradiol. 1991 Sep-Oct;12(5):829-34
pubmed: 1950905
Neurosurg Rev. 2022 Apr;45(2):1413-1420
pubmed: 34604940
Acta Neurochir (Wien). 2022 Jan;164(1):129-140
pubmed: 34853936
J Med Life. 2013 Jun 15;6(2):120-5
pubmed: 23904869
BMC Neurol. 2014 Jul 01;14:140
pubmed: 24986457

Auteurs

Christina Wolfert (C)

Department of Neurosurgery, University Hospital Augsburg, Stenglinstr. 2, 86156, Augsburg, Germany. christina.wolfert@uk-augsburg.de.

Christoph J Maurer (CJ)

Department of Neuroradiology, University Hospital Augsburg, Stenglinstr. 2, 86156, Augsburg, Germany.

Ansgar Berlis (A)

Department of Neuroradiology, University Hospital Augsburg, Stenglinstr. 2, 86156, Augsburg, Germany.

Hauke Schneider (H)

Department of Neurology, University Hospital Augsburg, Stenglinstr. 2, 86156, Augsburg, Germany.

Kathrin Steininger (K)

Department of Neurosurgery, University Hospital Augsburg, Stenglinstr. 2, 86156, Augsburg, Germany.

Stefan Motov (S)

Department of Neurosurgery, University Hospital Augsburg, Stenglinstr. 2, 86156, Augsburg, Germany.

Philipp Krauss (P)

Department of Neurosurgery, University Hospital Augsburg, Stenglinstr. 2, 86156, Augsburg, Germany.

Björn Sommer (B)

Department of Neurosurgery, University Hospital Augsburg, Stenglinstr. 2, 86156, Augsburg, Germany.

Ehab Shiban (E)

Department of Neurosurgery, University Hospital Augsburg, Stenglinstr. 2, 86156, Augsburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH